The utility of this platform in achieving these ends is here demonstrated by the discovery of a linear peptide derived from PfCSP which, when coupled to the VLP Qβ, generates neutralising antibodies capable of protecting mice against challenge with transgenic malaria parasites encoding P. falciparum CSP (PfCSP). This evidence concerns the gene DNAJC5 and malaria.